PSY31 Cost-Effectiveness of Tapentadol Prolonged-Release (Pr) Compared to Oxycodone Controlled Release (Cr) in Patients with Chronic Severe Non-Cancer Pain in Ireland
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.1003
https://www.valueinhealthjournal.com/article/S1098-3015(11)02565-4/fulltext
Title :
PSY31 Cost-Effectiveness of Tapentadol Prolonged-Release (Pr) Compared to Oxycodone Controlled Release (Cr) in Patients with Chronic Severe Non-Cancer Pain in Ireland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02565-4&doi=10.1016/j.jval.2011.08.1003
First page :
A415
Section Title :
Systemic Disorders/Conditions
Open access? :
No
Section Order :
957